| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Medicus Pharma Ltd. | Director | Common Shares, no par value ("Common Shares") | 35,435 | $74,413 | $2.10 | 29 Aug 2025 | Direct |
| Clovis Oncology, Inc. | President and Chief Executive Officer, Director | Stock Option (right to buy) | 80,000 | 01 Mar 2022 | Direct | ||
| Medicus Pharma Ltd. | Director | Stock Option (right to buy) | 25,000 | 16 Dec 2025 | Direct | ||
| Flexion Therapeutics Inc | Director | Common Stock | 0 | $8.50 | 19 Nov 2021 | Direct | |
| Flexion Therapeutics Inc | Director | Stock option (right to buy) | 0 | 19 Nov 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MDCX | Medicus Pharma Ltd. | 16 Dec 2025 | 1 | $0 | 4 | Director | 18 Dec 2025, 16:08 |
| MDCX | Medicus Pharma Ltd. | 29 Aug 2025 | 0 | $0 | 3 | Director | 08 Sep 2025, 16:36 |
| CLVS | Clovis Oncology, Inc. | 01 Mar 2022 | 3 | $0 | 4 | President and Chief Executive Officer, Director | 03 Mar 2022, 15:15 |
| FLXN | Flexion Therapeutics Inc | 19 Nov 2021 | 9 | -$338,504 | 4 | Director | 19 Nov 2021, 09:09 |
| FLXN | Flexion Therapeutics Inc | 24 Jun 2021 | 2 | $0 | 4 | Director | 28 Jun 2021, 18:24 |